Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2025-12-26 @ 2:43 AM
Study NCT ID:
NCT00606502
Status:
COMPLETED
Last Update Posted:
2021-03-05
First Post:
2008-01-22
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment
Sponsor:
Spectrum Pharmaceuticals, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-01
Start Date Type:
None
Primary Completion Date:
2010-06-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-06-24
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-22
First Submit QC Date:
None
Study First Post Date:
2008-02-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-12-22
Results First Submit QC Date:
None
Results First Post Date:
2011-01-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-08
Last Update Post Date:
2021-03-05
Last Update Post Date Type:
ACTUAL